Completed NA INTERVENTIONAL 1-arm NCT06075732

ACTIVATE in Public Housing

Academic-Community Team for Improving Vaccine Acceptability and Targeted Engagement: Public Housing

Sponsor: Charles Drew University of Medicine and Science

Conditions COVID-19 Influenza Meningitis Pneumonia Vaccine Hesitancy Varicella Zoster

Interventions Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination

Updated 4 times since 2023 Last updated: Feb 13, 2025 Started: Jul 1, 2024 Primary completion: Nov 30, 2024 Completion: Dec 2, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates COVID-19 and Influenza and is currently completed. Charles Drew University of Medicine and Science leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Completed NA

Status: Not Yet Recruiting → Completed
Sep 2024 — Mar 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Nov 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charles Drew University of Medicine and Science

Data source: Charles Drew University of Medicine and Science

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States